HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
Human T-cell leukemia virus type 1 (HTLV-1) causes both a neoplastic disease and inflammatory diseases, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The HTLV-1 basic leucine zipper factor (HBZ) gene is encoded in the minus strand of the proviral DNA and is constitutively expressed in infected cells and ATL cells. HBZ increases the number of regulatory T (Treg) cells by inducing the Foxp3 gene transcription. Recent studies have revealed that some CD4⁺Foxp3⁺ T cells are not terminally differentiated but have a plasticity to convert to other T-cell subsets. Induced Treg (iTreg) cells tend to lose Foxp3 expression, and may acquire an effector phenotype accompanied by the production of inflammatory cytokines, such as interferon-γ (IFN-γ). In this study, we analyzed a pathogenic mechanism of chronic inflammation related with HTLV-1 infection via focusing on HBZ and Foxp3. Infiltration of lymphocytes was observed in the skin, lung and intestine of HBZ-Tg mice. As mechanisms, adhesion and migration of HBZ-expressing CD4⁺ T cells were enhanced in these mice. Foxp3⁻CD4⁺ T cells produced higher amounts of IFN-γ compared to those from non-Tg mice. Expression of Helios was reduced in Treg cells from HBZ-Tg mice and HAM/TSP patients, indicating that iTreg cells are predominant. Consistent with this finding, the conserved non-coding sequence 2 region of the Foxp3 gene was hypermethylated in Treg cells of HBZ-Tg mice, which is a characteristic of iTreg cells. Furthermore, Treg cells in the spleen of HBZ-transgenic mice tended to lose Foxp3 expression and produced an excessive amount of IFN-γ, while Foxp3 expression was stable in natural Treg cells of the thymus. HBZ enhances the generation of iTreg cells, which likely convert to Foxp3⁻T cells producing IFN-γ. The HBZ-mediated proinflammatory phenotype of CD4⁺ T cells is implicated in the pathogenesis of HTLV-1-associated inflammation.
Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan.
Nanae
N
Yamamoto-Taguchi
Yorifumi
Y
Satou
Paola
P
Miyazato
Koichi
K
Ohshima
Masanori
M
Nakagawa
Koko
K
Katagiri
Tatsuo
T
Kinashi
Masao
M
Matsuoka
D000818:Animals; D050976:Basic-Leucine Zipper Transcription Factors / Q000235:genetics / Q000378:metabolism*; D002448:Cell Adhesion; D002465:Cell Movement; D002478:Cells, Cultured; D019175:DNA Methylation; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000378:metabolism*; D015490:HTLV-I Infections / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D015368:Human T-lymphotropic virus 1 / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000378:metabolism / Q000473:pathology / Q000821:virology; D008213:Lymphocyte Activation; D008297:Male; D008822:Mice, Transgenic; D015493:Paraparesis, Tropical Spastic / Q000209:etiology; D011994:Recombinant Proteins / Q000378:metabolism; D012191:Retroviridae Proteins; D013154:Spleen / Q000276:immunology / Q000378:metabolism / Q000473:pathology / Q000821:virology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000821:virology; D013950:Thymus Gland / Q000276:immunology / Q000378:metabolism / Q000473:pathology / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*
D050976:Basic-Leucine Zipper Transcription Factors; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; C479751:HBZ protein, human T-cell leukemia virus type I; D011994:Recombinant Proteins; D012191:Retroviridae Proteins; D014764:Viral Proteins; D007371:Interferon-gamma